Activation of NFkB is not a feature of multiple myeloma or Waldenstrom's macroglobulinemia.

被引：0
|
作者：
Leitch, D [1 ]
Barrans, SL [1 ]
Jack, A [1 ]
Owen, RG [1 ]
机构：
[1] Gen Infirm, HMDS Lab, Leeds LS1 3EX, W Yorkshire, England
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1534
引用
收藏
页码：395A / 395A
页数：1
相关论文
共 50 条
  • [31] Bcl-2 antisense treatment for Waldenstrom's macroglobulinemia.
    Nichols, GL
    Lin, N
    Sur, M
    Benimetskaya, L
    Stein, CA
    BLOOD, 2002, 100 (11) : 579A - 579A
  • [32] Prognostic factors add criteria to treat Waldenstrom's macroglobulinemia.
    Morel, P
    Duhamel, A
    Dimopoulos, M
    San Miguel, J
    Barlogie, B
    Kyle, R
    Leblond, V
    Dhodapkar, M
    Mc Coy, J
    Treon, S
    Gobbi, PG
    Merlini, G
    ANNALS OF ONCOLOGY, 2005, 16 : 261 - 262
  • [33] Hepatitis C viral infection is not associated with Waldenstrom's macroglobulinemia.
    Leleu, X
    O'Connor, K
    Ho, A
    Santos, DD
    Manning, R
    Xu, L
    Hatjiharissi, E
    Tournilhac, O
    Chemaly, M
    Branagan, AR
    Hunter, ZR
    Patterson, CJ
    Anderson, KC
    Treon, S
    BLOOD, 2005, 106 (11) : 253B - 253B
  • [34] Appropriateness of applying the response criteria for multiple myeloma to Waldenstrom's macroglobulinemia?
    Bladé, J
    Montoto, S
    Rosiñol, L
    Montserrat, E
    SEMINARS IN ONCOLOGY, 2003, 30 (02) : 329 - 331
  • [35] Calorimetric markers for monitoring of multiple myeloma and Waldenstrom's macroglobulinemia patients
    Todinova, Svetla
    Krumova, Sashka
    Danailova, Avgustina
    Petkova, Violeta
    Guenova, Margarita
    Mihaylov, Georgi
    Gartcheva, Lidia
    Taneva, Stefka Germanova
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2018, 47 (05): : 549 - 559
  • [36] Accumulation of inherited and acquired mutations in hyaluronan synthase1 gene may contribute oncogenesis in multiple myeloma and Waldenstrom's macroglobulinemia.
    Adamia, Sophia
    Hodges, Jennifer
    Pilarski, Patrick M.
    Treon, Steven
    Mant, Michael J.
    Reiman, Tony
    Belch, Andrew R.
    Pilarski, Linda M.
    BLOOD, 2006, 108 (11) : 980A - 980A
  • [37] Combination therapy with rituximab and fludarabine is highly active in Waldenstrom's macroglobulinemia.
    Treon, SP
    Wasi, P
    Emmanouilides, CA
    Frankel, SR
    Kimby, E
    Lister, A
    Morel, P
    Kelliher, A
    Branagan, A
    Preffer, F
    Anderson, KC
    BLOOD, 2002, 100 (11) : 211A - 211A
  • [38] Serum free light chain in waldenstrom macroglobulinemia.
    Moreau, Anne-Sophie
    Leleu, Xavier
    Manning, Robert
    Coiteux, Valerie
    Darre, Stephane
    Hatjiharisi, Evdoxia
    Hunter, Zachary
    Jia, Xiaoying
    Ngo, Hai
    O'Sullivan, Garrett
    Santos, Daniel
    Treon, Steven
    Facon, Thierry
    Anderson, Kenneth
    Ghobrial, Irene
    BLOOD, 2006, 108 (11) : 685A - 685A
  • [39] Predictors of disease progression in smoldering Waldenstrom macroglobulinemia.
    Zanwar, Saurabh
    Abeykoon, Jithma P.
    Ansell, Stephen M.
    Kumar, Shaji
    Dispenzieri, Angela
    Witzig, Thomas E.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [40] Analysis of chemokine and adhesion markers in waldenstrom macroglobulinemia.
    Ngo, Hai T.
    Leleu, Xavier
    Moreau, Anne-Sophie
    Hatjiharissi, Evodoxia
    Jia, Xiaoying
    O'Sullivan, Garrett
    Runnels, Judith
    Villarreal, Rose
    Hunter, Zachary
    Treon, Steven
    Hideshima, Teru
    Anderson, Kenneth
    Ghobrial, Irene
    BLOOD, 2006, 108 (11) : 244B - 244B
12345